HIV Media Digest 10 Feb

Paul Kidd — Thu, 09 Feb 2012 13:44:39 -0800

A roundup of HIV-related news from Australian and selected international media.

Vale Rodney Junga-Williams

Graham Stocks — Wed, 08 Feb 2012 16:42:47 -0800

Rodney Junga-Williams, a passionate advocate for indigenous Australians living with HIV, died in Sydney on 24 November 2011.

HIV Media Digest 8 Feb

Paul Kidd — Tue, 07 Feb 2012 13:15:42 -0800

A roundup of HIV-related news from Australian and selected international media.

Treataware activities update

Graham Stocks — Mon, 06 Feb 2012 20:55:45 -0800

Treataware organises Chin Wag events and Short Courses in HIV Medicine for Community and Industry, as well producing resources and factsheets on HIV care and treatments.

An number of Treataware activities for 2012 are now in place.

Famciclovir for genital herpes

Adrian Ogier — Mon, 06 Feb 2012 16:50:34 -0800

The trial is looking at how effective Famvir 500mg taken twice a day is for people with HIV who also suffer from acute outbreaks of gential herpes.

BMS-790052 for PLHIV with HCV

Adrian Ogier — Mon, 06 Feb 2012 15:24:38 -0800

The purpose of this open labelA clinical trial in which doctors and participants know which drug or vaccine is being administered. study is to evaluate the safety and efficacy(Of a drug or treatment). The maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the standard procedure, Phase II clinical trials gauge efficacy, and Phase III trials confirm it. of BMS-790052 plus Peg-Interferon Alfa 2a and RibavirinAn antiviral drug which is effective against a range of viruses including herpes, the hepatitis C virus and several strains of influenza. in people who have hepatitis C and are also living with HIV.

They will compare results with historic controls.

HIV Media Digest 6 Feb

Paul Kidd — Sun, 05 Feb 2012 14:06:45 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 3 Feb

Paul Kidd — Thu, 02 Feb 2012 17:02:52 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 1 Feb

Paul Kidd — Tue, 31 Jan 2012 14:03:46 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 30 Jan

Paul Kidd — Sun, 29 Jan 2012 13:19:35 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 25 Jan

Paul Kidd — Tue, 24 Jan 2012 15:57:28 -0800

A roundup of HIV-related news from Australian and selected international media.

RETRIeVE

Adrian Ogier — Mon, 23 Jan 2012 21:06:00 -0800

This is a retrospective review of people who have tried a combination including a non-nucleoside reverse transcriptase inhibitor (NNRTI) - such as efavirenz or nevirapine - but found that it didn't work.

The study aims to assess resistanceHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. profiling and subsequent prescription patterns of patients on NNRTIs

HIV Media Digest 20 Jan

Paul Kidd — Thu, 19 Jan 2012 14:00:25 -0800

A roundup of HIV-related news from Australian and selected international media.

MODERN (Maraviroc versus Truvada)

Adrian Ogier — Wed, 18 Jan 2012 20:03:38 -0800

The purpose of this study is to see whether maraviroc is just as good as Truvada (emtricitabine/tenofovir) at controlling HIV. One armAny of the treatment groups in a randomised trial. Most randomised trials have two "arms," but some have three "arms," or even more. of the study will take maraviroc once a day and the other will take Truvada once a day - both in combination with ritonavir-boosted darunavir. They will then compare the proportion of people with undetectable viral loads at week 48.

HIV Media Digest 18 Jan

Paul Kidd — Tue, 17 Jan 2012 15:40:40 -0800

A roundup of HIV-related news from Australian and selected international media.

Cobicistat and renal function

Adrian Ogier — Sun, 15 Jan 2012 20:51:45 -0800

The purpose of this study is to assess the effect of cobicistat-based regimens on the kidney function of PLHIVPerson (or people) Living with HIV. This term is now preferred over the older PLWHA. who already have mild to moderate renal impairment.

Cobicistat is a boosting agent and this study is trying to find the safest and most effective dose for people with existing kidney problems.

Gardasil for young men

Adrian Ogier — Sun, 15 Jan 2012 20:08:58 -0800

This ongoing study is evaluating the use of Gardasil in young men.

It hopes to demonstrate that the vaccine reduces the incidence of anogenital warts, penile/perianal/perineal intraepithelial neoplasia [PIN], penile/perianal/perineal cancer and Human Papilloma VirusA small infective organism which is incapable of reproducing outside a host cell. (HPV) infection in young men.

HIV Media Digest 16 Jan

Paul Kidd — Sun, 15 Jan 2012 13:52:01 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 11 Jan

Paul Kidd — Tue, 10 Jan 2012 14:05:55 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 9 Jan

Paul Kidd — Sun, 08 Jan 2012 12:54:03 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 21 Dec

admin — Tue, 20 Dec 2011 14:16:15 -0800

The final edition of HIV Media Digest for 2011.

HIV Media Digest 16 Dec

Paul Kidd — Thu, 15 Dec 2011 12:20:26 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 12 Dec

Paul Kidd — Sun, 11 Dec 2011 12:49:53 -0800

A roundup of HIV-related news from Australian and selected international media.

HIV Media Digest 19 Jan

Paul Kidd — Thu, 08 Dec 2011 15:32:32 -0800

A roundup of HIV-related news from Australian and selected international media.

DSP Impairment Table Review - NAPWA Update

Graham Stocks — Wed, 07 Dec 2011 17:16:42 -0800

As part of the Australian Government’s review of the Disability Support Pension, an Advisory Committee was established in April 2010. Since then there has been national consultation and analysis across the community based sector to support the development of reasonable and equitable Impairment Assessment Tables that best recognise people needing disability support, and that are appropriate for a wide range of illnesses and disabilities.